论文部分内容阅读
在美国和墨西哥 ,为了治疗勃起功能障碍 ,拜耳公司已申请批准磷酸二酯酶 5 (ＰＤＥ 5 )抑制剂瓦地那非 (ｖａｒｄｅｎａｆｉｌ)。这是首次对产品进行调整 ,期望在 2 0 0 2年下半年上市。不久公司将计划向欧盟申请批准。在礼莱 /艾科斯公司生产的ＩＣ35 1(Ｃｉａｌｉｓ)出现不
In the United States and Mexico, Bayer has applied for approval of the phosphodiesterase 5 (PDE 5) inhibitor vardenafil in order to treat erectile dysfunction. This is the first time the product has been adjusted to look forward to listing in the second half of 2002. The company will soon plan to apply for approval from the European Union. The IC35 1 (Cialis) produced at Leroy / Aikesi does not appear